Delivery Order SPE2DB20D3101-SPE2DB24FQYU3

Award Date 1/9/24
Potential Completion Date 1/10/24
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,471.18 firm-fixed-price delivery order is for the supply of 4,567,460,541 units of 5 mg oxycodone HCL immediate-release tablets. The contract has an ultimate completion date of March 5, 2025 and was awarded on March 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,108,069 units of oxycodone hydrochloride 5 mg tablets in 100-count bottles. The contract has a firm fixed price of $1,573.14 and a completion date of May 2, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,460.22, is for the delivery of 4,567,012,938 units of 5 mg Oxycodone HCL immediate-release tablets. The contract is a Firm Fixed Price Delivery Order with a period of performance through January 23, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,924,090 tablets of 5 mg oxycodone hydrochloride, an immediate-release pain medication. The contract has a firm fixed price of $1,359.64 and a performance period ending on April 16, 2025. This order is not associated with a set-aside program and is an open competition award. AmerisourceBergen Drug Corp...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $1,010.00 order is for the supply of 100 units of 5 mg oxycodone HCL immediate release tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through...
This federal contract award, valued at $1,729.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,476.76 delivery order contract covers the supply of 4,566,456,182 tablets of 5 mg Oxycodone HCL, an immediate-release opioid pain medication. The contract has a completion date of November 18, 2024 and uses a firm fixed-price pricing type. This award is not associated with a set-aside program. Amerisourcebergen...
The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract worth $1,401.96 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a Firm Fixed Price pricing type and a period of performance through November 2024, is for the delivery of OxyContin ER 10 mg tablets in 100-count bottles. This Delivery Order contract is associated with a larger Indefinite Delivery Contract...
This is a Delivery Order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,171.75, is for the delivery of 500 tablets of 5 mg Oxycodone HCL, a prescription pain medication. The award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, that allows the agency to efficiently procure a range of pharmaceutical and medical...
This federal contract award, valued at $1,203.40, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FQYU3
    Delivery Order

This contract award to AmerisourceBergen Drug Corp is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The delivery order is for 4,563,337,707 units of 5mg oxycodone hydrochloride immediate-release tablets, with a ceiling value of $2,965.32. This pharmaceutical product supports medical care for military personnel, veterans, and other federal beneficiaries. The contract has a firm fixed-price pricing type and does not have any set-aside designation, indicating open competition. As a major pharmaceutical distributor, AmerisourceBergen plays a critical role in supplying a wide range of essential medical commodities to federal government agencies, including the DLA and the Department of Justice Federal Bureau of Investigation, through its extensive supply chain and distribution capabilities.

Generated 2/27/25, 1:29 PM